| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.01e-05 | 530 | 21 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.38e-05 | 656 | 21 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.44e-05 | 658 | 21 | 6 | GO:0030312 | |
| Domain | TSP_1 | 2.07e-11 | 63 | 18 | 6 | PF00090 | |
| Domain | TSP1_rpt | 2.52e-11 | 65 | 18 | 6 | IPR000884 | |
| Domain | TSP1 | 2.52e-11 | 65 | 18 | 6 | PS50092 | |
| Domain | TSP1 | 2.52e-11 | 65 | 18 | 6 | SM00209 | |
| Domain | ADAM_spacer1 | 1.32e-06 | 23 | 18 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.32e-06 | 23 | 18 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.39e-04 | 24 | 18 | 2 | IPR013273 | |
| Domain | ADAM_Cys-rich | 3.04e-04 | 27 | 18 | 2 | IPR006586 | |
| Domain | ACR | 3.04e-04 | 27 | 18 | 2 | SM00608 | |
| Domain | Pep_M12B_propep | 6.36e-04 | 39 | 18 | 2 | PF01562 | |
| Domain | Peptidase_M12B_N | 6.36e-04 | 39 | 18 | 2 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 6.70e-04 | 40 | 18 | 2 | PS00427 | |
| Domain | Reprolysin | 6.70e-04 | 40 | 18 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 6.70e-04 | 40 | 18 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 6.70e-04 | 40 | 18 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 6.70e-04 | 40 | 18 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 7.04e-04 | 41 | 18 | 2 | IPR001762 | |
| Domain | - | 2.72e-03 | 81 | 18 | 2 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 2.72e-03 | 81 | 18 | 2 | IPR024079 | |
| Domain | ZINC_PROTEASE | 3.95e-03 | 98 | 18 | 2 | PS00142 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.57e-10 | 39 | 13 | 5 | MM15165 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.57e-10 | 39 | 13 | 5 | M27417 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.81e-09 | 68 | 13 | 5 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.09e-08 | 109 | 13 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.38e-08 | 111 | 13 | 5 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.21e-07 | 143 | 13 | 5 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.93e-06 | 250 | 13 | 5 | M27554 | |
| Pubmed | 1.01e-23 | 12 | 25 | 8 | 10433963 | ||
| Pubmed | 2.62e-23 | 13 | 25 | 8 | 17668377 | ||
| Pubmed | The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. | 3.15e-22 | 8 | 25 | 7 | 17588759 | |
| Pubmed | 4.72e-21 | 10 | 25 | 7 | 17984056 | ||
| Pubmed | 6.74e-20 | 13 | 25 | 7 | 7739628 | ||
| Pubmed | Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. | 7.63e-19 | 17 | 25 | 7 | 11245978 | |
| Pubmed | 1.41e-11 | 75 | 25 | 6 | 20637190 | ||
| Pubmed | The homeobox transcription factor DUXBL controls exit from totipotency. | 1.31e-09 | 4 | 25 | 3 | 38509386 | |
| Pubmed | 1.31e-09 | 4 | 25 | 3 | 17911620 | ||
| Pubmed | 3.28e-09 | 5 | 25 | 3 | 20063414 | ||
| Pubmed | The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection. | 1.15e-08 | 7 | 25 | 3 | 30765463 | |
| Pubmed | 1.48e-07 | 15 | 25 | 3 | 35727972 | ||
| Pubmed | 1.48e-07 | 15 | 25 | 3 | 30071041 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 24145033 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 17606262 | ||
| Pubmed | DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. | 2.97e-06 | 4 | 25 | 2 | 19829708 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 19359275 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 6.29e-06 | 50 | 25 | 3 | 31806660 | |
| Pubmed | 9.35e-05 | 20 | 25 | 2 | 19922873 | ||
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 3.43e-04 | 38 | 25 | 2 | 18267097 | |
| Pubmed | Quality Control of ER Membrane Proteins by the RNF185/Membralin Ubiquitin Ligase Complex. | 4.20e-04 | 42 | 25 | 2 | 32738194 | |
| Pubmed | LONP1-mediated mitochondrial quality control safeguards metabolic shifts in heart development. | 5.04e-04 | 46 | 25 | 2 | 35237793 | |
| Interaction | ADAMTS8 interactions | 7.52e-06 | 5 | 18 | 2 | int:ADAMTS8 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q35 | 1.45e-15 | 117 | 25 | 8 | chr4q35 | |
| Cytoband | 4q35.2 | 4.00e-15 | 27 | 25 | 6 | 4q35.2 | |
| Cytoband | 15q23 | 2.66e-04 | 44 | 25 | 2 | 15q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q23 | 6.34e-04 | 68 | 25 | 2 | chr15q23 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 5.14e-12 | 92 | 20 | 7 | 521 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.97e-04 | 19 | 20 | 2 | 50 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.65e-05 | 118 | 19 | 3 | d7dcffc0476a6e471debd83904a6569c6f27a594 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.09e-05 | 172 | 19 | 3 | 200b2e63313b110b8ca59ee5b72c02cc8ed907cd | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-05 | 174 | 19 | 3 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.45e-05 | 176 | 19 | 3 | f3bbe8c1a8d132705eac360cf531261271d84588 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.54e-05 | 177 | 19 | 3 | 928118b0ed120ec01c7d753ce523ab609ac24e5f | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.63e-05 | 178 | 19 | 3 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.63e-05 | 178 | 19 | 3 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.73e-05 | 179 | 19 | 3 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.05e-05 | 192 | 19 | 3 | 7bcdbd97fa8c3bfccde426d44979601226913fc3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.38e-05 | 195 | 19 | 3 | 157f1f9b0521c9eba11806eb4b6802ff116ab912 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-05 | 195 | 19 | 3 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.38e-05 | 195 | 19 | 3 | 95327f2818bcdca53dbd2971f674a9042a1392c6 | |
| ToppCell | (001)_CD16+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 7.49e-05 | 196 | 19 | 3 | 33843d550cbca03c044d593b1f6972e4d3871f7f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.49e-05 | 196 | 19 | 3 | 29246378ffb1010fe6858da756ae3d13df2306ba | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue | 7.49e-05 | 196 | 19 | 3 | 7fe97109a5a06b35fc081a85f341ea78da131323 | |
| ToppCell | Multiple_Sclerosis-Myeloid-CD16_Mono|Multiple_Sclerosis / Disease, Lineage and Cell Type | 7.49e-05 | 196 | 19 | 3 | 83011b56780295dff5ded57064b07dcd2f19ea26 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 7.49e-05 | 196 | 19 | 3 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | remission-Non-classical_Monocyte|remission / disease stage, cell group and cell class | 7.49e-05 | 196 | 19 | 3 | 049d995986c20ce066bd64fcc2d2f1c2f8899883 | |
| ToppCell | COVID-19_Severe-Myeloid-Non-classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class | 7.61e-05 | 197 | 19 | 3 | c5837b9a5a39a0f607a4e217ade9fc87d82a5406 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 7.61e-05 | 197 | 19 | 3 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|World / Disease group and Cell class | 7.61e-05 | 197 | 19 | 3 | 470784932e1fc3ff69f27cd83f56d85b0c01af63 | |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 7.61e-05 | 197 | 19 | 3 | 368644260f70895052a1d71171a9d882315354dd | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.72e-05 | 198 | 19 | 3 | 9b8679b3dd8f4220d71f607b7080cb88d6e71129 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.72e-05 | 198 | 19 | 3 | 8b6b602ebe59b6dca6a22f17385d3160ff3ac67e | |
| ToppCell | Healthy-Non-classical_Monocyte|Healthy / disease group, cell group and cell class | 7.72e-05 | 198 | 19 | 3 | 394e5fa8998c46c6f7cd57b53f347d2029c75ae1 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.72e-05 | 198 | 19 | 3 | 9b47585653aaebd033c9b7bba93c7a7c35a4d60e | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|Control_saline / Treatment groups by lineage, cell group, cell type | 7.72e-05 | 198 | 19 | 3 | c15ab0660a6de445a83396cf70860ea39868914d | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.72e-05 | 198 | 19 | 3 | 5436c3ed16e10e00c686f1ab0b0a68728a1a9985 | |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|mild_COVID-19 / disease group, cell group and cell class (v2) | 7.72e-05 | 198 | 19 | 3 | d7620b8d24e04ce1c563fc0ebe1625e03fe78950 | |
| ToppCell | remission-Non-classical_Monocyte|World / disease stage, cell group and cell class | 7.72e-05 | 198 | 19 | 3 | 1c170655070acca00520b7cf9c510a04c0a90a8f | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.72e-05 | 198 | 19 | 3 | 115f564af8d7b89ac0331d3831faaef694043fd4 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.72e-05 | 198 | 19 | 3 | 8b5d30312bbcabc6911ff03e5028766d77203dff | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.72e-05 | 198 | 19 | 3 | b9030390316baf456135f85f831394e1e11ecf3e | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.72e-05 | 198 | 19 | 3 | cbbdd44dfa95370c0fbaa65ba71d86bfee0ea379 | |
| ToppCell | Control-Myeloid-Non-classical_Monocyte|Control / Disease group, lineage and cell class | 7.72e-05 | 198 | 19 | 3 | ae0a51e63e2751a6d9dc0c8a3852680949173523 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.72e-05 | 198 | 19 | 3 | 7d8fade2583c07a33dd83057cbce08e9fc77987a | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 7.72e-05 | 198 | 19 | 3 | 8a97c8b2a43e6d1e669ce18752841e2006744bd9 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.72e-05 | 198 | 19 | 3 | 3bc3dbd178043deadd7eef413b2761dc003abd6e | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | 7.72e-05 | 198 | 19 | 3 | d4eae333fa100db3ea2d4cbe7a1d6ab14816f0e2 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.72e-05 | 198 | 19 | 3 | 4f67067d8142ca11b2d80195dac8d62a8d24d52c | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.72e-05 | 198 | 19 | 3 | c4a004f211f72f28aacbb512c6e075cbd049be53 | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|Healthy/Control / Disease group and Cell class | 7.72e-05 | 198 | 19 | 3 | 0badaf1fa5328d06291c3624d0f63196ffc81527 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.72e-05 | 198 | 19 | 3 | e8002972410e4803d85263ba2642e6855cef83e9 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.72e-05 | 198 | 19 | 3 | 165d60b111a17d517a420c434733eefb98da240d | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Monocytes,_Macrophages|Control_saline / Treatment groups by lineage, cell group, cell type | 7.72e-05 | 198 | 19 | 3 | 684f2dd5db889f118b5218ee23733cc1361272c2 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.72e-05 | 198 | 19 | 3 | ba3b97bb3e1533df758e845bde7d82eb1525b057 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.72e-05 | 198 | 19 | 3 | d36a3cda7e5f385d2391e9b0dfb027d3c4549320 | |
| ToppCell | Control_saline-Hematopoietic_Myeloid|Control_saline / Treatment groups by lineage, cell group, cell type | 7.84e-05 | 199 | 19 | 3 | 6be92062cce049a4c98f7311f2500bf1468fc267 | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.84e-05 | 199 | 19 | 3 | 3e09b3c2e2c57e5248981293020d2434e898e3e1 | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.84e-05 | 199 | 19 | 3 | ae6b4b4557c6a9223acdee2a79bc780c5916d38a | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.84e-05 | 199 | 19 | 3 | 99eec995aa20ac22a8dd045382bd15a15db0b87a | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.84e-05 | 199 | 19 | 3 | 4eed28ef8c74d7131eeeabdd732a682d91e034dd | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.84e-05 | 199 | 19 | 3 | f234533254fd82b1ef2041e8405fe201d874018b | |
| ToppCell | COVID-19_Convalescent-Myeloid-Non-classical_Monocyte|COVID-19_Convalescent / Disease group, lineage and cell class | 7.84e-05 | 199 | 19 | 3 | 5253948a1d7fc3da571860e14cdde4e18222e13b | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.84e-05 | 199 | 19 | 3 | aca9f75c690c6ed952bcbdc7e1e7eef7719f54ca | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-CD16+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class | 7.96e-05 | 200 | 19 | 3 | 58fbb7fc7159cbc417e6b457d60b7beba9b90da6 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-CD16+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class | 7.96e-05 | 200 | 19 | 3 | 5c0eb14bdf1bfeaf93f6c3d521529bd5a4de50ce | |
| ToppCell | COVID-19-COVID-19_Convalescent-Myeloid-CD16+_Monocyte|COVID-19_Convalescent / Disease, condition lineage and cell class | 7.96e-05 | 200 | 19 | 3 | f24abb2d54d6423ee886285e3c66a874ec59e1a3 | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-CD16+_Monocyte|Multiple_Sclerosis / Disease, condition lineage and cell class | 7.96e-05 | 200 | 19 | 3 | add2f9fbada3a68662edc8c756af90cdc380295b | |
| ToppCell | Control-Control-Myeloid-CD16+_Monocyte|Control / Disease, condition lineage and cell class | 7.96e-05 | 200 | 19 | 3 | 8dd124a5aca897652ea68efbfc5a167b4cf31aef | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.96e-05 | 200 | 19 | 3 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Notum_(Notum)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.37e-04 | 81 | 19 | 2 | c9145c994abcf49e5492270b18b0580a3d771ccf | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Notum_(Notum)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.37e-04 | 81 | 19 | 2 | f84bfa55c6b9548f8829b16a145690d207a7bfc1 | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Notum_(Notum)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.37e-04 | 81 | 19 | 2 | 34d2a2c30c749bd2ad447dfb1e43444953d9b154 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-04 | 94 | 19 | 2 | 00b932421d77f0fd8d6ffe439c992ebc95ad7c94 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.10e-03 | 116 | 19 | 2 | c19974992b315fb873664fe3f5077ff8e907e30c | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 1.17e-03 | 120 | 19 | 2 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-03 | 121 | 19 | 2 | a5962d1c476e6966870832b72d511607e047248b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-03 | 126 | 19 | 2 | cde3b0fbdc324120e45e295eb171ee550653de47 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-03 | 128 | 19 | 2 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.37e-03 | 130 | 19 | 2 | a3e12984fb61311e49cc76c59f74f4dffc48faa1 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.39e-03 | 131 | 19 | 2 | f2eee150f5cff852e8f52f09b35e26f17d80833b | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.41e-03 | 132 | 19 | 2 | dc6edfa821a1cdc645668b0af5ba5ff80dee10bd | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-03 | 132 | 19 | 2 | f8e2ba53063007d7507f1837ad669b0e4333cd23 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.41e-03 | 132 | 19 | 2 | 60ced08bda5efc95a6f116cd0c6d1a779d99ed38 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.44e-03 | 133 | 19 | 2 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.46e-03 | 134 | 19 | 2 | 3dd4b5eddc94c1d49ab23b287ee234db3a55331b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.48e-03 | 135 | 19 | 2 | 54b2aaf8d322e01a3ff6099c2422d68ecccf96b4 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-03 | 137 | 19 | 2 | b03f19b233c1c809f2cd2b4a7642eeaf254a6289 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.52e-03 | 137 | 19 | 2 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.52e-03 | 137 | 19 | 2 | 5e97480f014f1d9267e8126f1d0e58acd22f36aa | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.54e-03 | 138 | 19 | 2 | 86435f004f7525630d0cc0626b553d7adfc9db19 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 139 | 19 | 2 | 292533e04178dd36d57377562077f9deb2cb9746 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 139 | 19 | 2 | 22a769d5195ed761ef333ef542746e1ba617a698 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 140 | 19 | 2 | 39083c3e288d1878fdc4c798e600fb156daff8a9 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 140 | 19 | 2 | 06e14a375ea85175c809ff5a0ea16e865ccb4ad5 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.61e-03 | 141 | 19 | 2 | a32947b13e888850c979a54c137512e4b96d2f36 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.61e-03 | 141 | 19 | 2 | 2cb651d63466fdcce011d1dd8de409ef439d03e7 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-03 | 142 | 19 | 2 | 39ada235a46f2202c093cf2336de224a5957ed1a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.68e-03 | 144 | 19 | 2 | 0bbe670454846cf9bc7464ae4e91488415c4111d | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-03 | 146 | 19 | 2 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-mDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-03 | 147 | 19 | 2 | 26bd9d89e2e7b841cc18030bb7cebb642b987183 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-03 | 148 | 19 | 2 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.80e-03 | 149 | 19 | 2 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-03 | 151 | 19 | 2 | 7b50425d2bbd7b6ff2a6e67d3e2470a4455740e0 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-03 | 152 | 19 | 2 | bfc7ef4ee26165d18ac4f475a9519e8d52453ba2 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-03 | 152 | 19 | 2 | 962f5bf632da79bd933193d3edd7d89941a85831 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.89e-03 | 153 | 19 | 2 | 5fbb90b8477f9fdabf3be19efd3068fbf70abee6 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.89e-03 | 153 | 19 | 2 | 2c46183481e6d5a7fa190a743062509465f88e56 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.89e-03 | 153 | 19 | 2 | decc4f3098a9374a6b65c015a9d36380986290bf | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.06e-03 | 105 | 19 | 2 | DOID:9352 (implicated_via_orthology) | |
| Disease | HMG CoA reductase inhibitor use measurement | 6.50e-03 | 189 | 19 | 2 | EFO_0009932 | |
| Disease | obesity (implicated_via_orthology) | 8.33e-03 | 215 | 19 | 2 | DOID:9970 (implicated_via_orthology) | |
| Disease | longevity | 1.42e-02 | 284 | 19 | 2 | EFO_0004300 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CPVEGQWLEWGPWGP | 416 | O60241 | |
| PKPVADGGWAPWGPW | 521 | Q9UP79 | |
| DGGWAPWGPWGECSR | 526 | Q9UP79 | |
| PPTSQGSPWWGWGRG | 301 | P0CJ87 | |
| GSPWWGWGRGPQVAG | 306 | P0CJ87 | |
| PPTSQGSPWWGWGRG | 301 | P0CJ89 | |
| GSPWWGWGRGPQVAG | 306 | P0CJ89 | |
| GCWGGPWRPPPPGFW | 86 | Q8TC90 | |
| AARLHPWWGGGGWPA | 51 | O94925 | |
| PWWGGGGWPAEPLAR | 56 | O94925 | |
| PPTSQGSPWWGWGRG | 301 | Q9UBX2 | |
| GSPWWGWGRGPQVAG | 306 | Q9UBX2 | |
| PPTSQGSPWWGWGRG | 301 | P0CJ86 | |
| GSPWWGWGRGPQVAG | 306 | P0CJ86 | |
| PWALWGRGPAIGGQW | 51 | P36776 | |
| QCCPEMGGWSGWGPW | 131 | P27918 | |
| NIPQAGGWGPWGPWG | 516 | O75173 | |
| GGWGPWGPWGDCSRT | 521 | O75173 | |
| PPTSQGSPWWGWGRG | 301 | Q6RFH8 | |
| GSPWWGWGRGPQVAG | 306 | Q6RFH8 | |
| PPTSQGSPWWGWGRG | 301 | P0CJ90 | |
| GSPWWGWGRGPQVAG | 306 | P0CJ90 | |
| DPAPGGWGWGWAGGG | 371 | Q86UW8 | |
| PPTSQGSPWWGWGRG | 301 | P0CJ88 | |
| GSPWWGWGRGPQVAG | 306 | P0CJ88 | |
| GRWAWPMPGWGPACP | 261 | Q8IUY3 | |
| PPSGGGWAGWGSWGK | 121 | Q8IWE2 | |
| PSWPCPWGKGRPGWH | 331 | P49589 | |
| DRAGGWGPWGPWSHC | 3251 | A2VEC9 | |
| PVDGAWGPWGPWSPC | 3471 | A2VEC9 | |
| WGPWGPWSPCDMCLG | 3476 | A2VEC9 | |
| WPGPGGVWGPWAPSS | 226 | Q8N205 | |
| GGPWGDWAWPEMCPD | 41 | Q7Z5L0 | |
| GDCWPGWFGPWGVPR | 91 | Q969Z4 | |
| GAPGVWGAWGPWSAC | 51 | Q6ZMP0 | |
| PPTSQGSPWWGWGRG | 301 | P0CJ85 | |
| GSPWWGWGRGPQVAG | 306 | P0CJ85 | |
| GLDGGWWAPPPPPWA | 1201 | O15399 |